|
Cyclic Nucleotide Phosphodiesterases, Type 2
|
D12.776.476.008.200 |
|
|
Pediatric Nursing
|
H02.478.676.631 |
|
|
Prostaglandin H2
|
D01.339.431.374.744.650.500 |
|
|
Prostaglandins H
|
D01.339.431.374.744.650 |
|
|
Piscirickettsiaceae Infections
|
C01.150.252.400.719 |
|
|
Genes, erbA
|
G05.360.340.024.340.375.500.791.290 |
|
|
Proto-Oncogenes
|
G05.360.340.024.340.375.500.791 |
|
|
WAGR Syndrome
|
C19.391.119.096.875 |
|
|
Loligo
|
B01.050.500.644.116.150.500 |
|
|
Decapodiformes
|
B01.050.500.644.116.150 |
|
|
NAV1.8 Voltage-Gated Sodium Channel
|
D12.776.543.585.400.875.750.800 |
|
|
Cytochrome P-450 CYP1A1
|
D08.811.682.690.708.170.020.500 |
|
|
Telocytes
|
A11.329.830.750 |
|
|
Urinary Bladder, Underactive
|
C23.888.942.343.790 |
|
|
Arsenites
|
D01.075.050 |
|
|
Arsenicals
|
D01.075 |
|
|
N95 Respirators
|
D000087162 |
[Respiratory protective devices designed to achieve a close seal around the nose and mouth to maintain efficient filtration of aerosolized particles and droplets. They are often fitted for the prevention of the spread of infections (e.g. COVID19) or to administer inhaled anesthetics or other gases.
] |
|
Genes, erbB
|
G05.360.340.024.340.375.500.791.295 |
|
|
Bioaccumulation
|
G03.787.024.500.187 |
|
|
Injections
|
E02.319.267.530 |
|
